BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 294470)

  • 1. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 3. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
    Ehrly AM
    Angiology; 1976 Mar; 27(3):188-96. PubMed ID: 1078314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
    Pilla G; Ciaponi A; Migliavacca A; Bonora C
    Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
    Müller R; Schröer R
    J Med; 1979; 10(5):347-64. PubMed ID: 393790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
    Perego MA; Sergio G; Artale F; Giunti P; Danese C
    Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial occlusive disease: reducing blood viscosity through drugs].
    Gnauen H
    Med Klin; 1981 Feb; 76(5):144-6. PubMed ID: 7219342
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F; Rotatori P; Frausini G
    Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W; Leube G
    Med Welt; 1979 Sep; 30(37):1367-9. PubMed ID: 502814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.